- List
- By Topic
- On Map
- Search Details

Hereditary Neuropathies
Need help? See RSS Feeds
Choose a feed type:

Hereditary Neuropathies (86 records)
Need help? See Downloading Content for Analysis
For Advanced Users: Full Study Record XML Download
1 | NCT02788734 | Completed | Patient Reported Outcomes Measures (PROM) in Carpal Tunnel Therapies in Patients With Inherited Neuropathies |
|
|
Observational |
|
Other / NIH |
|
|
333 | All | 18 Years and older (Adult, Senior) | NCT02788734 | INC6612 U01TR001263 |
June 2016 | November 19, 2016 | November 19, 2016 | June 2, 2016 | March 15, 2018 |
|
|||
2 | NCT02429947 | Completed | An Analysis of the Symptomatic Domains Most Relevant to Charcot Marie Tooth Neuropathy (CMT) Patients |
|
Observational |
|
Other / NIH |
|
|
411 | All | 18 Years and older (Adult, Senior) | NCT02429947 | INC6606 5U54NS064808-07 |
July 2012 | June 2013 | June 2013 | April 29, 2015 | June 14, 2017 |
|
||||
3 | NCT03278093 | Recruiting | Effect of Orthoses and Underfoot Vibration on Balance in Neuropathy |
|
Observational |
|
Other |
|
|
15 | All | 18 Years and older (Adult, Senior) | NCT03278093 | 16.0029 | October 20, 2017 | July 20, 2018 | July 20, 2018 | September 11, 2017 | March 21, 2018 |
|
||||
4 | NCT01733407 | Completed | L-Serine Supplementation in Hereditary Sensory Neuropathy Type 1 |
|
|
Interventional | Phase 1 Phase 2 |
|
Other |
|
|
18 | All | 18 Years and older (Adult, Senior) | NCT01733407 | FD-R-04127-01 | September 2013 | May 2017 | July 2017 | November 27, 2012 | July 14, 2017 |
|
||
5 | NCT02194010 | Recruiting | Disability Severity Scale (DSI) and Hereditary Motor and Sensory Neuropathy Overall Disability Scale (HMSN-R-ODS) |
|
Observational |
|
Other / NIH |
|
|
415 | All | 10 Years and older (Child, Adult, Senior) | NCT02194010 | INC 6610 U54NS065712 |
DSI and HMSN | April 2014 | December 2018 | December 2018 | July 18, 2014 | October 5, 2017 |
|
|||
6 | NCT01401257 | Completed Has Results |
Phase II, Randomized, Placebo-controlled Trial in Patients With Charcot-marie-tooth Disease Type 1A |
|
|
Interventional | Phase 2 |
|
Other |
|
|
80 | All | 18 Years to 65 Years (Adult) | NCT01401257 | CLN-PXT3003-01 | December 2010 | October 2011 | December 2012 | July 25, 2011 | November 22, 2017 | February 16, 2017 |
|
|
7 | NCT02001038 | Completed | Survey of Current Management of Orthopaedic Complications in CMT Patients |
|
|
Observational |
|
Other / NIH |
|
|
16 | All | Child, Adult, Senior | NCT02001038 | INC 6608 | February 2013 | November 2014 | November 2014 | December 4, 2013 | January 30, 2015 |
|
|||
8 | NCT02982343 | Recruiting | BALTiC Study: A Feasibility Analysis of Home Based BALance Training in People With Charcot-Marie-Tooth Disease |
|
|
Interventional | Not Applicable |
|
Other |
|
|
16 | All | 18 Years and older (Adult, Senior) | NCT02982343 | 16/LO/0720 | BALTiC | December 2016 | November 2017 | November 2017 | December 5, 2016 | September 11, 2017 |
|
|
9 | NCT01568658 | Recruiting | Genetic and Physical Study of Childhood Nerve and Muscle Disorders |
|
Observational |
|
NIH |
|
5650 | All | Child, Adult, Senior | NCT01568658 | 120095 12-N-0095 |
March 14, 2012 | April 2, 2012 | March 29, 2018 |
|
|||||||
10 | NCT01900132 | Recruiting | Electrical Impedance Myography: Exploratory Studies in Healthy People and People With Neuromuscular Disorders |
|
Observational |
|
NIH |
|
|
250 | All | 2 Years and older (Child, Adult, Senior) | NCT01900132 | 130165 13-N-0165 |
July 11, 2013 | April 1, 2019 | April 1, 2019 | July 16, 2013 | April 5, 2018 |
|
||||
11 | NCT01455623 | Completed | Development and Validation of a Disability Severity Index for CMT |
|
Observational |
|
Other / NIH |
|
|
291 | All | 8 Years and older (Child, Adult, Senior) | NCT01455623 | INC-6604 | 6604 | June 2011 | March 2014 | March 2014 | October 20, 2011 | March 26, 2014 |
|
|||
12 | NCT01267422 | Completed Has Results |
Safety and Efficacy Study of rAAV2-ND4 Treatment of Leber Hereditary Optic Neuropathy (LHON) |
|
|
Interventional | Not Applicable |
|
Other |
|
|
9 | All | 8 Years to 60 Years (Child, Adult) | NCT01267422 | RAVCT-2 | rAAV2-ND4 | April 2011 | November 2015 | November 2015 | December 28, 2010 | January 31, 2018 | May 2, 2016 |
|
13 | NCT00747487 | Completed | Study to Assess Efficacy,Safety and Tolerability of Idebenone in the Treatment of Leber's Hereditary Optic Neuropathy |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
85 | All | 14 Years to 65 Years (Child, Adult) | NCT00747487 | SNT-II-003 | RHODOS | November 2007 | February 2010 | February 2010 | September 5, 2008 | May 27, 2013 |
|
|
14 | NCT03153293 | Recruiting | Safety and Efficacy Study of Gene Therapy for The Treatment of Leber's Hereditary Optic Neuropathy |
|
|
Interventional | Phase 2 Phase 3 |
|
Other |
|
|
40 | All | 10 Years to 65 Years (Child, Adult) | NCT03153293 | Leber 2 | December 27, 2017 | December 30, 2018 | June 30, 2019 | May 15, 2017 | January 9, 2018 |
|
||
15 | NCT02064569 | Active, not recruiting | Safety Evaluation of Gene Therapy in Leber Hereditary Optic Neuropathy (LHON) Patients |
|
|
Interventional | Phase 1 Phase 2 |
|
Industry |
|
|
21 | All | 18 Years and older (Adult, Senior) | NCT02064569 | GS-LHON/CLIN/01 | February 2014 | June 2020 | June 2020 | February 17, 2014 | April 6, 2018 |
|
||
16 | NCT01389817 | Terminated Has Results |
Near-infrared Light-emitting Diode (NIR-LED) Therapy for Leber's Hereditary Optic Neuropathy (LHON) |
|
|
Interventional | Phase 1 Phase 2 |
|
Other |
|
|
4 | All | 18 Years and older (Adult, Senior) | NCT01389817 | PRO14842 | LHON | July 2011 | May 2013 | May 2013 | July 8, 2011 | September 29, 2014 | September 29, 2014 |
|
17 | NCT02876939 | Enrolling by invitation | Proprioception and Sensorimotor Control in Hereditary Sensory and Autonomic Neuropathy |
|
|
Interventional | Not Applicable |
|
Other |
|
|
30 | All | 16 Years to 40 Years (Child, Adult) | NCT02876939 | 16-00530 | November 2016 | June 2018 | June 2018 | August 24, 2016 | July 13, 2017 |
|
||
18 | NCT02300753 | No longer available | Emergency Administration of EPI-743 to a Single Patient With Leber's Hereditary Optic Neuropathy [LHON] |
|
|
Expanded Access |
|
Industry | All | 8 Years to 65 Years (Child, Adult) | NCT02300753 | EPI-2010-004 | November 25, 2014 | November 25, 2014 |
|
|||||||||
19 | NCT02796274 | Recruiting | Historical Case Record Survey of Visual Acuity Data From Patients With Leber's Hereditary Optic Neuropathy (LHON) |
|
Observational |
|
Industry |
|
|
100 | All | 12 Years and older (Child, Adult, Senior) | NCT02796274 | SNT-CRS-002 | May 2016 | April 2017 | June 10, 2016 | March 3, 2017 |
|
|||||
20 | NCT02161380 | Recruiting | Safety Study of an Adeno-associated Virus Vector for Gene Therapy of Leber's Hereditary Optic Neuropathy |
|
|
Interventional | Phase 1 |
|
Other / NIH |
|
|
27 | All | 15 Years and older (Child, Adult, Senior) | NCT02161380 | 20140248 1U10EY023558-01A1 |
LHON | July 2014 | March 2019 | March 2019 | June 11, 2014 | January 25, 2018 |
|
|
21 | NCT02693119 | Active, not recruiting | A Study Investigating the Safety, Tolerability, and Efficacy of Elamipretide (MTP-131) Topical Ophthalmic Solution for the Treatment of Leber's Hereditary Optic Neuropathy |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
12 | All | 18 Years to 50 Years (Adult) | NCT02693119 | SPILH-201 | March 2016 | May 2018 | May 2018 | February 26, 2016 | September 11, 2017 |
|
||
22 | NCT00528151 | Completed | A Randomized, Double-blind, Placebo-controlled Trial of Curcumin in Leber's Hereditary Optic Neuropathy (LHON) |
|
|
Interventional | Phase 3 |
|
Other |
|
|
70 | All | 8 Years and older (Child, Adult, Senior) | NCT00528151 | 123/2547 | May 2005 | December 2007 | September 12, 2007 | December 24, 2012 |
|
|||
23 | NCT02176733 | Unknown † | Trial of Cyclosporine in the Acute Phase of Leber Hereditary Optic Neuropathy |
|
|
Interventional | Phase 2 |
|
Other |
|
|
12 | All | 18 Years and older (Adult, Senior) | NCT02176733 | PHRC 2010-05 | CICLO-NOHL | July 2011 | October 2015 | June 27, 2014 | June 27, 2014 |
|
||
24 | NCT01892943 | Completed | Leber Hereditary Optic Neuropathy (LHON) Historical Case Record Survey |
|
Observational |
|
Industry / Other |
|
|
306 | All | Child, Adult, Senior | NCT01892943 | LHON HCR | August 2013 | February 2014 | February 2014 | July 8, 2013 | May 15, 2014 |
|
||||
25 | NCT01421381 | Completed | RHODOS Follow-up Single-visit Study |
|
Observational |
|
Industry |
|
|
60 | All | 15 Years to 69 Years (Child, Adult, Senior) | NCT01421381 | SNT-II-003-OFU | RHODOS-OFU | September 2011 | November 2011 | December 2011 | August 22, 2011 | May 27, 2013 |
|
|||
26 | NCT03295071 | Not yet recruiting | REALITY LHON Registry |
|
|
Observational |
|
Industry |
|
|
50 | All | Child, Adult, Senior | NCT03295071 | GS010_Registry_001 | REALITY | December 2017 | March 2019 | March 2019 | September 27, 2017 | December 4, 2017 | |||
27 | NCT01495715 | Withdrawn | Study With Idebenone in Patients With Chronic Vision Loss Due to Leber's Hereditary Optic Neuropathy (LHON) |
|
|
Interventional | Phase 3 |
|
Industry | 0 | All | 10 Years to 65 Years (Child, Adult) | NCT01495715 | SNT-III-011 | December 20, 2011 | August 22, 2014 | ||||||||
28 | NCT03293524 | Recruiting | Efficacy and Safety Study of Bilateral Intravitreal Injection of GS010 for the Treatment of Vision Loss up to 1 Year From Onset in LHON Due to the ND4 Mutation |
|
|
Interventional | Phase 3 |
|
Industry |
|
|
90 | All | 15 Years and older (Child, Adult, Senior) | NCT03293524 | GS-LHON-CLIN-05 2017-002187-40 |
REFLECT | March 12, 2018 | June 30, 2020 | June 30, 2021 | September 26, 2017 | April 9, 2018 |
|
|
29 | NCT02771379 | Recruiting | Post Authorisation Safety Study With Raxone in LHON Patients |
|
|
Observational |
|
Industry |
|
|
250 | All | Child, Adult, Senior | NCT02771379 | SNT-IV-003 | PAROS | September 2016 | February 2021 | May 13, 2016 | July 7, 2017 |
|
|||
30 | NCT02774005 | Recruiting | Study to Assess the Efficacy and Safety of Raxone in LHON Patients |
|
|
Interventional | Phase 4 |
|
Industry |
|
|
250 | All | 12 Years and older (Child, Adult, Senior) | NCT02774005 | SNT-IV-005 | LEROS | May 2016 | April 2020 | May 16, 2016 | November 27, 2017 |
|
||
31 | NCT00271635 | Completed | Ascorbic Acid Treatment in CMT1A Trial (AATIC) |
|
|
Interventional | Phase 2 |
|
Other |
|
|
13 | All | 12 Years to 25 Years (Child, Adult) | NCT00271635 | 04/320 | AATIC | January 2006 | July 2007 | July 2007 | January 4, 2006 | July 4, 2008 |
|
|
32 | NCT01902940 | Completed | Natural History in CCFDN and IBM Syndromes |
|
|
Observational |
|
Other |
|
|
350 | All | Child, Adult, Senior | NCT01902940 | CCFDN-IBM-2013 | June 2013 | September 2013 | October 2013 | July 18, 2013 | September 1, 2015 |
|
|||
33 | NCT03406104 | Recruiting | RESCUE and REVERSE Long-term Follow-up |
|
|
Observational |
|
Industry |
|
|
74 | All | 15 Years and older (Child, Adult, Senior) | NCT03406104 | GS-LHON-CLIN-06 2017-002153-11 |
RESCUE/REVERSE | January 9, 2018 | July 2022 | August 2022 | January 23, 2018 | April 4, 2018 |
|
||
34 | NCT02765828 | Recruiting | Identification of Tongue Involvement in Late-Onset Pompe Disease |
|
|
Observational |
|
Other / Industry |
|
|
70 | All | 12 Years and older (Child, Adult, Senior) | NCT02765828 | Pro00068729 | May 2016 | April 2019 | April 2019 | May 9, 2016 | April 4, 2018 |
|
|||
35 | NCT00004568 | Recruiting | Study of Inherited Neurological Disorders |
|
Observational |
|
NIH | 2500 | All | 2 Years and older (Child, Adult, Senior) | NCT00004568 | 000043 00-N-0043 |
February 8, 2000 | February 14, 2000 | April 4, 2018 |
|
||||||||
36 | NCT01847937 | Completed | Magnetic Resonance Diagnostics of Diabetic Peripheral Neuropathy |
|
Observational |
|
Other |
|
|
115 | All | 18 Years to 90 Years (Adult, Senior) | NCT01847937 | 1-10-72-85-13 VEK: 1-10-72-85-13 |
May 2013 | September 2016 | September 2016 | May 7, 2013 | February 3, 2017 |
|
||||
37 | NCT01289704 | Unknown † | Treadmill, Stretching and Proprioceptive Exercise (TreSPE) Rehabilitation Program for Charcot−Marie−Tooth Neuropathy Type 1A (CMT1A) |
|
|
Interventional | Phase 2 Phase 3 |
|
Other |
|
|
92 | All | 18 Years to 70 Years (Adult, Senior) | NCT01289704 | GUP09013 | TreSPE | February 2011 | October 2011 | January 2012 | February 4, 2011 | February 4, 2011 |
|
|
38 | NCT03190577 | Recruiting | Assessment of the Prevalence of TTR Amyloid Neuropathy in a Population of Patients With Neuropathy of Unknown Aetiology |
|
|
Interventional | Not Applicable |
|
Other / Industry |
|
|
400 | All | 18 Years to 90 Years (Adult, Senior) | NCT03190577 | RC16_0427 | PRE-TRANS | September 21, 2017 | January 30, 2021 | January 30, 2021 | June 19, 2017 | November 21, 2017 |
|
|
39 | NCT02939820 | Available | Expanded Access Protocol of Patisiran for Patients With Hereditary ATTR Amyloidosis (hATTR) |
|
|
Expanded Access |
|
Industry | All | 18 Years and older (Adult, Senior) | NCT02939820 | ALN-TTR02-007 | October 20, 2016 | February 7, 2018 |
|
|||||||||
40 | NCT03268681 | Recruiting | BIOtinidase Test In Optic-Neuropathy |
|
Observational |
|
Other |
|
|
30 | All | Child, Adult, Senior | NCT03268681 | RDS_2017_14 | BIOTIN | July 26, 2017 | September 2018 | April 2019 | August 31, 2017 | September 6, 2017 |
|
|||
41 | NCT02564484 | Recruiting | iPSC Neurons From Adult Survivors of Childhood Cancer Who Have Persistent Vincristine-Induced Neuropathy |
|
Observational |
|
Other / NIH |
|
|
200 | All | 18 Years and older (Adult, Senior) | NCT02564484 | SJLPSC R01CA036401 |
February 8, 2016 | February 2020 | February 2023 | September 30, 2015 | March 1, 2018 |
|
||||
42 | NCT03373370 | Recruiting | Early Diagnosis of TTR Amyloidosis by Use of Molecular Biology |
|
Observational |
|
Other |
|
|
1000 | All | 51 Years and older (Adult, Senior) | NCT03373370 | NI 16007 | ADDITION | March 17, 2017 | March 27, 2018 | March 16, 2019 | December 14, 2017 | January 17, 2018 |
|
|||
43 | NCT00017745 | Completed | Phenotype/Genotype Correlations in Neuromuscular Disorders |
|
Observational |
|
NIH | 1000 | All | Child, Adult, Senior | NCT00017745 | 010187 01-N-0187 |
June 1, 2001 | May 10, 2007 | June 11, 2001 | July 2, 2017 |
|
|||||||
44 | NCT03431896 | Recruiting | Monitoring of Early Disease Progression in Hereditary Transthyretin Amyloidosis |
|
Observational |
|
Other |
|
|
10 | All | Child, Adult, Senior | NCT03431896 | 17-1301 | MED-hATTR | February 1, 2018 | February 15, 2024 | February 15, 2024 | February 13, 2018 | February 13, 2018 |
|
|||
45 | NCT03237494 | Recruiting | Screening for Hereditary Transthyretin Related Amyloidosis-an Nationales, Multicentre, Epidemiological Protocol |
|
Observational |
|
Other / Industry |
|
|
5000 | All | 18 Years to 70 Years (Adult, Senior) | NCT03237494 | TRAM analysis 06-2017 | TRAM | July 20, 2017 | June 2019 | July 2019 | August 2, 2017 | August 3, 2017 |
|
|||
46 | NCT02696746 | Recruiting | Painful Channelopathies Study |
|
|
Observational |
|
Other |
|
|
100 | All | 18 Years to 99 Years (Adult, Senior) | NCT02696746 | 12/LO/0017 | PCS | February 2012 | January 2019 | March 2, 2016 | February 16, 2018 |
|
|||
47 | NCT03475173 | Recruiting New |
New Non-invasive Modalities for Assessing Retinal Structure and Function |
|
|
Interventional | Not Applicable |
|
Other |
|
|
500 | All | 18 Years to 99 Years (Adult, Senior) | NCT03475173 | 201611825 | May 6, 2014 | January 1, 2020 | January 1, 2020 | March 23, 2018 | March 26, 2018 |
|
||
48 | NCT00389935 | Completed | Thalidomide Reduces Arteriovenous Malformation Related Gastrointestinal Bleeding |
|
|
Interventional | Phase 2 |
|
U.S. Fed / Other |
|
|
14 | All | 18 Years and older (Adult, Senior) | NCT00389935 | 00198 | TAG | October 2006 | June 2011 | July 2011 | October 19, 2006 | August 2, 2011 |
|
|
49 | NCT03428178 | Recruiting | Efficacy Study of Gene Therapy for The Treatment of Acute LHON Onset Within Three Months |
|
|
Interventional | Not Applicable |
|
Other |
|
|
50 | All | 8 Years to 60 Years (Child, Adult) | NCT03428178 | LHON(Acute) | LHON | January 8, 2018 | January 30, 2018 | January 30, 2020 | February 9, 2018 | April 10, 2018 |
|
|
50 | NCT02600286 | Recruiting | Ulipristal Acetate In Disease Charcot-Marie-Tooth Type of 1A |
|
|
Interventional | Phase 2 |
|
Other |
|
|
45 | Male | 18 Years to 70 Years (Adult, Senior) | NCT02600286 | 6100 | UPACOMT | October 23, 2015 | October 23, 2018 | October 23, 2018 | November 9, 2015 | May 17, 2017 |
|
† Study has passed its completion date and status has not been verified in more than two years.